Pharmacologic Treatments in Adults With Type 2 Diabetes: Cost-Effectiveness and Comorbidity Considerations

Affiliations

Editorial

Fatima Z Syed. Ann Intern Med. 2024 May.

. 2024 May;177(5):680-681.

doi: 10.7326/M24-0861. Epub 2024 Apr 19.

¹ Duke University Division of General Internal Medicine, Durham, North Carolina.

No abstract available

Conflict of interest statement

Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M24-0861.

Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Clinical Guideline From the American College of Physicians.
Qaseem A, Obley AJ, Shamliyan T, Hicks LA, Harrod CS, Crandall CJ; Clinical Guidelines Committee of the American College of Physicians; Balk EM, Cooney TG, Cross JT Jr, Fitterman N, Lin JS, Maroto M, Miller MC, Shekelle P, Tice JA, Tufte JE, Etxeandia-Ikobaltzeta I, Yost J. Qaseem A, et al. Ann Intern Med. 2024 May;177(5):658-666. doi: 10.7326/M23-2788. Epub 2024 Apr 19. Ann Intern Med. 2024. PMID: 38639546 Free PMC article.